Home » Stocks » Genetron Holdings

Genetron Holdings Limited (GTH)

Stock Price: $13.01 USD 1.17 (9.88%)
Updated Jul 2, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 1.18B
Revenue (ttm) 46.20M
Net Income (ttm) -96.58M
Shares Out 88.36M
EPS (ttm) n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 2, 2020
Last Price $13.01
Previous Close $11.84
Change ($) 1.17
Change (%) 9.88%
Day's Open 11.91
Day's Range 11.91 - 13.38
Day's Volume 574,451
52-Week Range 11.09 - 17.71

More Stats

Market Cap 1.18B
Enterprise Value 1.15B
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 88.36M
Float 17.43M
EPS (basic) n/a
EPS (diluted) n/a
FCF / Share -0.34
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short n/a
Short Ratio n/a
Short % of Float n/a
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 25.56
PB Ratio n/a
Revenue 46.20M
Operating Income -43.84M
Net Income -96.58M
Free Cash Flow -30.48M
Net Cash 27.79M
Net Cash / Share 0.31
Gross Margin 44.83%
Operating Margin -94.88%
Profit Margin -209.00%
FCF Margin -65.96%
ROA n/a
ROE n/a
ROIC -280.20%
Key stats in USD, based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

*No analysts have provided price targets for this stock.

Financial Performance

Financial numbers in millions CNY.

Financial Overview

Revenue Growth43.63%122.87%-
Gross Profit14592.7326.82
Operating Income-307-233-153
Net Income-676-465-421
Shares Outstanding442--
Earnings Per Share-27.05-20.45-23.20
Operating Cash Flow-197-201-130
Capital Expenditures-16.38-43.91-19.17
Free Cash Flow-213-245-149
Cash & Equivalents262101295
Total Debt67.64--
Net Cash / Debt195101295
Book Value-1,778-1,064-622
Numbers in millions CNY, except per-share numbers.

Company Profile

Company Details

Full Name Genetron Holdings Limited
Country China
Employees 697
CEO Si Zhen Wang

Stock Information

Ticker Symbol GTH
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: GTH
IPO Date June 19, 2020


Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early liver cancer screening services through laboratory developed tests services, such as HCCscreen, a proprietary assay for the early screening of liver cancer. It also provides in-vitro diagnostics products, including 8-gene Lung Cancer Assay, an IVD assay product based on semiconductor sequencing to detect lung cancer; Genetron 3D biochip reading instrument; IDH1/TERT gene assays for glioma; GENETRON S5, a semiconductor sequencer used in the field of gene detection; and Genetron S2000 that enables gene panel sequencing. In addition, the company develops ctDNA Lung Cancer assay for mutations in the epidermal growth factor receptor gene. It also offers development services in the areas of genomics research and clinical development in collaboration with biopharmaceutical companies, hospitals, and research institutions worldwide. The company was founded in 2015 and is headquartered in Beijing, the People's Republic of China.